Home / Market News / $ALGN

$ALGN news and market catalysts

The 23 most recent market catalysts affecting $ALGN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

23 catalysts 5 high impact 9 bullish 11 bearish Healthcare
Nov 18, 2026 Corporate Catalyst Neutral Impact 55
Align Technology Appoints Paul J. Clancy and Ian Bell to Board of Directors
Align Technology is adding two experienced executives, Paul J. Clancy and Ian Bell, to its Board of Directors. Clancy brings a strong background from Alexion Pharmaceuticals and Bi…
Nov 9, 2026 Corporate Catalyst Bullish Impact 85
Align Technology Reports Q3 2026 Financial Results and Announces Global Restructuring
Align Technology (ALGN) reported Q3 2026 revenue of $1.01 billion, a 1.9% increase year-over-year, and a net profit of $135.04 million. While the financial results show modest grow…
Nov 6, 2026 Corporate Catalyst Bullish Impact 65
Align Technology Executes Accelerated Share Repurchase with Goldman Sachs
Align Technology has announced an accelerated share repurchase (ASR) agreement with Goldman Sachs to buy back $270 million of its common stock. This action is a common corporate st…
Nov 6, 2026 Corporate Catalyst Bullish Impact 65
Align Technology Announces $270 Million Accelerated Stock Repurchase Agreement
Align Technology has entered into a $270 million accelerated stock repurchase (ASR) agreement. This action demonstrates the company's commitment to returning capital to shareholder…
Oct 28, 2026 Corporate Catalyst Neutral Impact 75
Align Technology Issues Fourth Quarter 2026 Revenue Guidance
Align Technology, Inc. released its financial outlook for the fourth quarter of 2026, guiding revenue to be in the range of $1.00 billion to $1.02 billion. This guidance is signifi…
Oct 28, 2026 Corporate Catalyst Bullish Impact 92
Align Technology Reports Third Quarter 2026 Financial Results
Align Technology announced its Q3 2026 financial results, reporting revenue of $1.015 billion and adjusted EPS of $2.80, both surpassing analyst expectations. This strong beat on k…
Oct 28, 2026 Corporate Catalyst Neutral Impact 75
Align Technology Announces CEO Succession Plan
Align Technology has announced a planned CEO transition, with Jennifer L. Davis succeeding Joseph M. Hogan effective December 31, 2026. This is a significant leadership change for …
Oct 27, 2026 Corporate Catalyst Bearish Impact 60
UBS Adjusts Price Target on Align Technology to $186 From $205, Maintains Neutral Rating
UBS has reduced its price target for Align Technology (ALGN) from $205 to $186, while maintaining a 'Neutral' rating. This action signals a more cautious stance from the investment…
Oct 22, 2026 Corporate Catalyst Bearish Impact 55
Mizuho Securities Adjusts Align Technology Price Target to $200 From $220
Mizuho Securities has adjusted its financial outlook for Align Technology, Inc., lowering its price target from $220 to $200. This action reflects a revised valuation assessment by…
Oct 19, 2026 Corporate Catalyst Bearish Impact 75
Reported Friday, Align Wins Unified Patent Court Case Against Angelalign, With Torque Ridges Found To Infringe European Patent For Power Ridge Technology
This patent victory for Align Technology (ALGN) is a significant corporate catalyst. It reinforces Align's intellectual property moat, particularly for its 'Power Ridge' technology…
Oct 15, 2026 Corporate Catalyst Bearish Impact 65
This Align Technology Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
The filing details several analyst downgrades across different companies and sectors. For Envista Holdings, Cirrus Logic, ZTO Express, and Align Technology, the downgrades are acco…
Oct 15, 2026 Corporate Catalyst Bearish Impact 65
Baird Downgrades Align Technology to Neutral, Lowers Price Target to $162
Baird's downgrade of Align Technology from Outperform to Neutral, coupled with a substantial price target reduction from $218 to $162, signals a significant shift in analyst sentim…
Oct 9, 2026 Corporate Catalyst Bearish Impact 65
Stifel Maintains Buy on Align Technology, Lowers Price Target to $175
Stifel analyst Jonathan Block maintained a 'Buy' rating on Align Technology (ALGN) but lowered the price target from $210 to $175. This action signals that while the analyst still …
Oct 6, 2026 Market Technicals Bearish Impact 55
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter
This filing identifies three healthcare stocks—Align Technology (ALGN), Dianthus Therapeutics (DNTH), and Ocular Therapeutix (OCUL)—as oversold based on their RSI values being belo…
Oct 5, 2026 Corporate Catalyst Bearish Impact 65
Align Technology, Group 1 Automotive And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
The primary drivers of the pre-market declines for Align Technology and Group 1 Automotive are analyst downgrades and significant price target cuts. For ALGN, Evercore ISI Group mo…
Oct 5, 2026 Corporate Catalyst Bearish Impact 65
Evercore ISI Group Downgrades Align Technology to In-Line, Lowers Price Target to $155
Evercore ISI Group's downgrade of Align Technology from 'Outperform' to 'In-Line' and a substantial reduction in its price target from $220 to $155 signals a significant shift in a…
Aug 12, 2026 Corporate Catalyst Bullish Impact 75
Reported Earlier, Align Technology Secures China Patent Win Against Angelalign, Following Prior UPC And Pending ITC Rulings
Align Technology's patent win in China is a significant corporate catalyst, as it directly impacts the competitive landscape in the lucrative clear aligner market. This victory cou…
Jul 30, 2026 Corporate Catalyst Bearish Impact 85
Align Technology shares are trading lower after the company reported Q2 financial results and issued Q3 sales guidance with its midpoint below estimates.
This headline represents a significant corporate catalyst for Align Technology. The lower Q2 results and particularly the Q3 sales guidance falling below estimates suggest a decele…
Jul 29, 2026 Corporate Catalyst Bullish Impact 85
Align Technology Says For Fiscal 2027, Currently Expect GAAP & Non-GAAP Operating Margins To Increase At Least About 100 Basis Points YoY
Align Technology's projection of at least 100 basis points YoY increase in operating margins for fiscal 2027 is a significant positive catalyst. This indicates management's confide…
Jul 29, 2026 Corporate Catalyst Bullish Impact 75
Align Advances Board Refresh And Strategic Initiatives After Constructive Engagement With Elliott
Align Technology has announced a series of strategic initiatives, including adding three new independent directors with relevant expertise and launching a comprehensive strategic a…
Jul 29, 2026 Corporate Catalyst Bullish Impact 75
Align Technology Announces Increased 2026 Share Buyback Commitment Of $400M-$500M
This announcement is a significant corporate catalyst for Align Technology. Share buybacks reduce the number of outstanding shares, which can increase earnings per share (EPS) and …
Jul 29, 2026 Corporate Catalyst Bearish Impact 85
Align Technology shares are trading lower. The company reported Q2 financial results.
The headline indicates a direct corporate catalyst: Align Technology's Q2 financial results. The 'trading lower' aspect suggests the results were perceived negatively by the market…
Jul 29, 2026 Corporate Catalyst Bullish Impact 75
Align Tech Q2 Adj. EPS $2.64 Beats $2.61 Estimate, Sales $1.056B Beat $1.052B Estimate
Align Technology (ALGN) reported Q2 adjusted EPS of $2.64, exceeding the $2.61 estimate, and sales of $1.056 billion, beating the $1.052 billion estimate. This performance represen…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.